Increased collagen deposition and diastolic dysfunction but preserved myocardial hypertrophy after pressure overload in mice lacking PKCepsilon
- PMID: 15761199
- DOI: 10.1161/01.RES.0000161999.86198.1e
Increased collagen deposition and diastolic dysfunction but preserved myocardial hypertrophy after pressure overload in mice lacking PKCepsilon
Abstract
Overexpression and activation of protein kinase C-epsilon (PKCepsilon) results in myocardial hypertrophy. However, these observations do not establish that PKCepsilon is required for the development of myocardial hypertrophy. Thus, we subjected PKCepsilon-knockout (KO) mice to a hypertrophic stimulus by transverse aortic constriction (TAC). KO mice show normal cardiac morphology and function. TAC caused similar cardiac hypertrophy in KO and wild-type (WT) mice. However, KO mice developed more interstitial fibrosis and showed enhanced expression of collagen Ialpha1 and collagen III after TAC associated with diastolic dysfunction, as assessed by tissue Doppler echocardiography (Ea/Aa after TAC: WT 2.1+/-0.3 versus KO 1.0+/-0.2; P<0.05). To explore underlying mechanisms, we analyzed the left ventricular (LV) expression pattern of additional PKC isoforms (ie, PKCalpha, PKCbeta, and PKCdelta). After TAC, expression and activation of PKCdelta protein was increased in KO LVs. Moreover, KO LVs displayed enhanced activation of p38 mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase (JNK), whereas p42/p44-MAPK activation was attenuated. Under stretch, cultured KO fibroblasts showed a 2-fold increased collagen Ialpha1 (col Ialpha1) expression, which was prevented by PKCdelta inhibitor rottlerin or by p38 MAPK inhibitor SB 203580. In conclusion, PKCepsilon is not required for the development of a pressure overload-induced myocardial hypertrophy. Lack of PKCepsilon results in upregulation of PKCdelta and promotes activation of p38 MAPK and JNK, which appears to compensate for cardiac hypertrophy, but in turn, is associated with increased collagen deposition and impaired diastolic function.
Comment in
-
Cardiac hypertrophy served with protein kinase Cepsilon: delta isoform substitution available at additional cost.Circ Res. 2005 Apr 15;96(7):711-3. doi: 10.1161/01.RES.0000164185.96546.82. Circ Res. 2005. PMID: 15831822 No abstract available.
Similar articles
-
Deletion of the inducible 70-kDa heat shock protein genes in mice impairs cardiac contractile function and calcium handling associated with hypertrophy.Circulation. 2006 Jun 6;113(22):2589-97. doi: 10.1161/CIRCULATIONAHA.105.598409. Epub 2006 May 30. Circulation. 2006. PMID: 16735677
-
Mitogen-activated protein kinases (p38 and c-Jun NH2-terminal kinase) are differentially regulated during cardiac volume and pressure overload hypertrophy.Cell Biochem Biophys. 2005;43(1):61-76. doi: 10.1385/CBB:43:1:061. Cell Biochem Biophys. 2005. PMID: 16043884
-
PKC mediates cyclic stretch-induced cardiac hypertrophy through Rho family GTPases and mitogen-activated protein kinases in cardiomyocytes.J Cell Physiol. 2005 Feb;202(2):536-53. doi: 10.1002/jcp.20151. J Cell Physiol. 2005. PMID: 15316932
-
[The role of angiotensin II in the development of cardiovascular remodeling].Nihon Rinsho. 1999 May;57(5):1090-5. Nihon Rinsho. 1999. PMID: 10361440 Review. Japanese.
-
Mechanotransduction in cardiac myocytes.Ann N Y Acad Sci. 2004 May;1015:53-70. doi: 10.1196/annals.1302.005. Ann N Y Acad Sci. 2004. PMID: 15201149 Review.
Cited by
-
Emergence of Members of TRAF and DUB of Ubiquitin Proteasome System in the Regulation of Hypertrophic Cardiomyopathy.Front Genet. 2018 Aug 21;9:336. doi: 10.3389/fgene.2018.00336. eCollection 2018. Front Genet. 2018. PMID: 30186311 Free PMC article. Review.
-
Pharmacological inhibition of epsilon-protein kinase C attenuates cardiac fibrosis and dysfunction in hypertension-induced heart failure.Hypertension. 2008 Jun;51(6):1565-9. doi: 10.1161/HYPERTENSIONAHA.107.109637. Epub 2008 Apr 14. Hypertension. 2008. PMID: 18413490 Free PMC article.
-
Mechanisms of cardiac collagen deposition in experimental models and human disease.Transl Res. 2019 Jul;209:138-155. doi: 10.1016/j.trsl.2019.03.004. Epub 2019 Mar 26. Transl Res. 2019. PMID: 30986384 Free PMC article. Review.
-
Pharmacological Protein Kinase C Modulators Reveal a Pro-hypertrophic Role for Novel Protein Kinase C Isoforms in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.Front Pharmacol. 2021 Jan 20;11:553852. doi: 10.3389/fphar.2020.553852. eCollection 2020. Front Pharmacol. 2021. PMID: 33584253 Free PMC article.
-
Protein kinase C in heart failure: a therapeutic target?Cardiovasc Res. 2009 May 1;82(2):229-39. doi: 10.1093/cvr/cvp001. Epub 2009 Jan 24. Cardiovasc Res. 2009. PMID: 19168855 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous